Progressive cardiac dysfunction and fibrosis in the cardiomyopathic hamster and effects of growth hormone and angiotensin-converting enzyme inhibition

被引:80
作者
Ryoke, T
Gu, Y
Mao, L
Hongo, M
Clark, RG
Peterson, KL
Ross, J
机构
[1] Univ Calif San Diego, Dept Med 0613B, Div Cardiol, La Jolla, CA 92093 USA
[2] Genentech Inc, San Francisco, CA 94080 USA
关键词
myocardium; collagen; ventricles; hypertrophy; cardiomyopathy;
D O I
10.1161/01.CIR.100.16.1734
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Growth hormone (GH) improves cardiac function in the rat with myocardial infarction, but its effects in a model of primary dilated cardiomyopathy have not been reported. GPI effects were examined at early (4 months) and late (10 months) phases of disease in the cardiomyopathic (CM) hamster, and the combination of GH with chronic ACE inhibition was assessed in late-phase heart failure. Methods and Results-CM hamsters (CHF 147 line) at 4 months showed severe systolic left ventricular (LV) dysfunction with normal LV filling pressure, and at 10 months then was more severe systolic as well as diastolic dysfunction with increasing myocardial fibrosis. Recombinant human GH alone for 3 weeks at age 4 months increased LV wall thickness and reduced systolic wall stress without altering diastolic wall stress, whereas at 10 months, wall stress and fractional shortening did not improve. The LV dP/dt(max) was enhanced at both ages by GH, which at 4 months reflected increased contractility. but at 10 months was most likely caused by elevation of the LV filling pressure. The increasing degree of fibrosis correlated inversely with LV function but was unaffected by GH. In other CM hamsters, high-dose ACE inhibition alone (quinapril), started at 8 months and continued for Il weeks, improved LV function and inhibited unfavorable remodeling, but the addition of CH for 3 weeks at age 10 months produced increased wall thickness with little additional functional benefit and increased the LV filling pressure and diastolic wall stress. Conclusions-GH treatment alone improved LV dysfunction at 4 months of age in CM hamsters by increasing contractility and reducing wall stress but had few beneficial effects at 10 months in seven LV failure, After chronic ACE inhibition, addition of GH at 10 months had no additional beneficial effects and further increased LV diastolic pressure, These differing effects of GH may relate to the progressive increase of LV fibrosis in the CM hamster.
引用
收藏
页码:1734 / 1743
页数:10
相关论文
共 28 条
[11]  
Hongo M, 1998, J Card Fail, V4, P213, DOI 10.1016/S1071-9164(98)80008-0
[12]  
LEI LQ, 1988, LAB INVEST, V59, P357
[13]   THE LEFT-VENTRICULAR DP/DTMAX-END-DIASTOLIC VOLUME RELATION IN CLOSED-CHEST DOGS [J].
LITTLE, WC .
CIRCULATION RESEARCH, 1985, 56 (06) :808-815
[14]   EXPANSION OF EXTRACELLULAR VOLUME AND SUPPRESSION OF ATRIAL-NATRIURETIC-PEPTIDE AFTER GROWTH-HORMONE ADMINISTRATION IN NORMAL MAN [J].
MOLLER, J ;
JORGENSEN, JOL ;
MOLLER, N ;
HANSEN, KW ;
PEDERSEN, EB ;
CHRISTIANSEN, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (04) :768-772
[15]   Identification of the syrian hamster cardiomyopathy gene [J].
Nigro, V ;
Okazaki, Y ;
Belsito, A ;
Piluso, G ;
Matsuda, Y ;
Politano, L ;
Nigro, G ;
Ventura, C ;
Abbondanza, C ;
Molinari, AM ;
Acampora, D ;
Nishimura, M ;
Hayashizaki, Y ;
Puca, GA .
HUMAN MOLECULAR GENETICS, 1997, 6 (04) :601-607
[16]   Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy [J].
Osterziel, KJ ;
Strohm, O ;
Schuler, J ;
Friedrich, M ;
Hänlein, D ;
Willenbrock, R ;
Anker, SD ;
Poole-Wilson, PA ;
Ranke, MB ;
Dietz, R .
LANCET, 1998, 351 (9111) :1233-1237
[17]  
PALIKODETI V, 1997, AM J PHYSIOL, V273, pH1283
[18]   AFTERLOAD MISMATCH AND PRELOAD RESERVE - CONCEPTUAL FRAMEWORK FOR ANALYSIS OF VENTRICULAR-FUNCTION [J].
ROSS, J .
PROGRESS IN CARDIOVASCULAR DISEASES, 1976, 18 (04) :255-264
[19]   Growth hormone, cardiomyocyte contractile reserve, and heart failure [J].
Ross, J .
CIRCULATION, 1999, 99 (01) :15-17
[20]   ACQUIRED GROWTH-HORMONE RESISTANCE [J].
ROSS, RJM ;
CHEW, SL .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (06) :655-660